与GLP-1受体激活剂相关的功能和美学外周,眼膜和眼表面变化
Dimitrios Kapantais1,2, Panagiotis Tsoutsanis1,2
1Department of Ophthalmology, Northern Care Alliance NHS Foundation Trust, Rochdale OL12 0NB, UK.
Journal of clinical medicine
|December 30, 2025
概括
葡萄糖类-1 (GLP-1) 受体激活剂可以导致面部体积丧失,称为"Ozempic face. 在接受治疗的患者中,意识是管理这些美学和功能变化的关键.
科学领域:
- 内分泌学和新陈代谢学
- 皮肤病学 皮肤病学
- 眼科医生 眼科 眼科
背景情况:
- GLP-1和GIP受体激活剂对肥胖和2型糖尿病有效.
- 这些药物与对面部和眼部组织的不良美学和功能影响有关.
研究的目的:
- 审查与GLP-1和GLP-1/GIP受体激动剂相关的面部和眼部变化的文献.
- 了解这些变化的机制和影响.
主要方法:
- 在PubMed,Embase和Medline进行全面的文献搜索.
- 包括报告面部,周围轨道,轨道或眼睛表面变化的研究.
- 对参考清单进行选,以寻找其他相关来源.
主要成果:
- GLP-1/GIP激动剂可能会导致快速的面部体积损失,皮肤脂肪缩,以及周期性空洞化 ("Ozempic face").
- 机制包括脂肪消耗和脂肪细胞调节;在某些情况下,观察到眼睛表面的改善.
- 放射学数据显示,偏好表面中脸部脂肪损失,指导美学纠正.
结论:
- 虽然GLP-1疗法是有效的,但可能会导致美学和功能上的副/周眼部变化.
- 跨学科的管理和意识对于解决这些副作用至关重要.
- 需要进一步的前性研究来澄清机制和指导干预措施.
相关概念视频
Glucagon-like Receptor Agonists
816
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
816
Open Angle Glaucoma: Treatment
920
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
920
Accessory Structures of the Eye
3.3K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
3.3K
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K


